HKPD
Cellyan Biotechnology Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · HK
$2.19
+0.44%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.56x
- Price / sales
- 0.40x
- Price / cash flow
- -7.19x
Enterprise value
- Enterprise value
- $6.4M
- EV / sales
- 0.48x
- EV / EBITDA
- -8.82x
- EV / EBIT
- -6.47x
- Market cap
- $5.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026